156 related articles for article (PubMed ID: 32813287)
1. Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
Yang SR; Hsu WH; Wu CY; Shang HS; Liu FC; Chen A; Hua KF; Ka SM
FASEB J; 2020 Oct; 34(10):13284-13299. PubMed ID: 32813287
[TBL] [Abstract][Full Text] [Related]
2. Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice.
Lin TJ; Wu CY; Tsai PY; Hsu WH; Hua KF; Chu CL; Lee YC; Chen A; Lee SL; Lin YJ; Hsieh CY; Yang SR; Liu FC; Ka SM
Front Immunol; 2019; 10():1951. PubMed ID: 31475012
[TBL] [Abstract][Full Text] [Related]
3. Tris DBA Ameliorates Accelerated and Severe Lupus Nephritis in Mice by Activating Regulatory T Cells and Autophagy and Inhibiting the NLRP3 Inflammasome.
Wu CY; Hua KF; Chu CL; Yang SR; Arbiser JL; Yang SS; Lin YC; Liu FC; Yang SM; Ka SM; Chen A
J Immunol; 2020 Mar; 204(6):1448-1461. PubMed ID: 32060137
[TBL] [Abstract][Full Text] [Related]
4. Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation.
Ka SM; Lin JC; Lin TJ; Liu FC; Chao LK; Ho CL; Yeh LT; Sytwu HK; Hua KF; Chen A
Arthritis Res Ther; 2015 Nov; 17():331. PubMed ID: 26584539
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory suppression and immunity regulation benefits of honokiol in a rat model of acute peritonitis via the regulation of NLRP3 inflammasome and Sirt1/autophagy axis.
Pan X; Hua Z; Fan G; Feng Q
Histol Histopathol; 2024 Jul; 39(7):921-934. PubMed ID: 38112214
[TBL] [Abstract][Full Text] [Related]
6. Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus.
Ye JS; Chen L; Lu YY; Lei SQ; Peng M; Xia ZY
Oxid Med Cell Longev; 2019; 2019():8639618. PubMed ID: 30918581
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca
Tian J; Huang T; Chen J; Wang J; Chang S; Xu H; Zhou X; Yang J; Xue Y; Zhang T; Fan W; Wang Y
Clin Exp Med; 2023 Nov; 23(7):3465-3478. PubMed ID: 37261640
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis.
Bonomini F; Dos Santos M; Veronese FV; Rezzani R
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311094
[TBL] [Abstract][Full Text] [Related]
9. Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis.
Tsai PY; Ka SM; Chang JM; Lai JH; Dai MS; Jheng HL; Kuo MT; Chen P; Chen A
Arthritis Rheum; 2012 Jan; 64(1):232-42. PubMed ID: 21905011
[TBL] [Abstract][Full Text] [Related]
10. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome.
Peng X; Yang T; Liu G; Liu H; Peng Y; He L
Int Immunopharmacol; 2018 Dec; 65():448-457. PubMed ID: 30388519
[TBL] [Abstract][Full Text] [Related]
11. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
12. Cf-02, a novel benzamide-linked small molecule, blunts NF-κB activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice.
Yang SR; Hua KF; Yang CY; Chen A; Weng JC; Tsai YL; Wan CJ; Wu CY; Lee CC; Chan JF; Hsieh CY; Hsu YJ; Wu CC; Mukhopadhyay D; Huang HS; Liu FC; Ka SM
FASEB J; 2021 Aug; 35(8):e21785. PubMed ID: 34314075
[TBL] [Abstract][Full Text] [Related]
13. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
14. Xenon blunts NF-κB/NLRP3 inflammasome activation and improves acute onset of accelerated and severe lupus nephritis in mice.
Yang SR; Hua KF; Chu LJ; Hwu YK; Yang SM; Wu CY; Lin TJ; Weng JC; Zhao H; Hsu WH; Liu FC; Liaw WJ; Ma D; Ka SM; Chen A
Kidney Int; 2020 Aug; 98(2):378-390. PubMed ID: 32622527
[TBL] [Abstract][Full Text] [Related]
15. Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction.
Wu CY; Hua KF; Yang SR; Tsai YS; Yang SM; Hsieh CY; Wu CC; Chang JF; Arbiser JL; Chang CT; Chen A; Ka SM
J Cell Mol Med; 2020 Dec; 24(23):13609-13622. PubMed ID: 33135320
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.
Tsai PY; Ka SM; Chang JM; Chen HC; Shui HA; Li CY; Hua KF; Chang WL; Huang JJ; Yang SS; Chen A
Free Radic Biol Med; 2011 Aug; 51(3):744-54. PubMed ID: 21641991
[TBL] [Abstract][Full Text] [Related]
17. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.
Zhang H; Liu L; Li L
J Pharmacol Sci; 2018 Aug; 137(4):342-349. PubMed ID: 30190171
[TBL] [Abstract][Full Text] [Related]
19. Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3/IL-33/ST2 axis.
Ma Q; Xu M; Jing X; Qiu J; Huang S; Yan H; Yin L; Lou J; Zhao L; Fan Y; Qiu P
Cell Death Dis; 2023 Mar; 14(3):174. PubMed ID: 36859530
[TBL] [Abstract][Full Text] [Related]
20. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Zhao J; Zhang H; Huang Y; Wang H; Wang S; Zhao C; Liang Y; Yang N
Int Immunopharmacol; 2013 Sep; 17(1):116-22. PubMed ID: 23770281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
